Neasa Hourigan (Dublin Central, Green Party)
Link to this: Individually | In context | Oireachtas source

That is not great, given that drug innovation happens. We would like there to be a fairly dynamic response from organisations. I want to go back to the registry's issue. This has come up a number of times in other sectors to do with healthcare and anything that is a long-term condition. In a practical sense, what is the hold-up? What is the problem? Is it that there are different systems across different hospital groups? Is it that, as has been aired a lot this morning, not enough data is being gathered? What are the hold-ups on the ground to those being rolled out?